Publicaciones en las que colabora con MARÍA LUZ HERNÁNDEZ GÁLVEZ (36)

2017

  1. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

    PLoS ONE, Vol. 12, Núm. 4

  2. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

    Methods in Enzymology (Academic Press Inc.), pp. 175-198

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

2010

  1. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders

    CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3

2007

  1. An overview on the biochemistry of the cannabinoid system

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 3-14

2004

  1. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ 9 -tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence

    Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170

  2. Cannabinoids and gene expression during brain development

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401

2003

  1. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.

    Brain research. Developmental brain research, Vol. 147, Núm. 1-2, pp. 201-207

2002

  1. Exposure to cannabinoids in the development of endogenous cannabinoid system

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 363-372

2000

  1. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

    Brain Research, Vol. 857, Núm. 1-2, pp. 56-65

  2. The endogenous cannabinoid system and brain development

    Trends in Neurosciences, Vol. 23, Núm. 1, pp. 14-20

1999

  1. Role of endocannabinoids in brain development

    Life Sciences, Vol. 65, Núm. 6-7, pp. 725-736

1998

  1. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development

    Development, Vol. 125, Núm. 16, pp. 3179-3188

1997

  1. Atypical location of cannabinoid receptors in white matter areas during rat brain development

    Synapse, Vol. 26, Núm. 3, pp. 317-323

  2. Δ9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons

    Journal of Molecular Neuroscience, Vol. 8, Núm. 2, pp. 83-91

1995

  1. The prenatal exposure to δ9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development

    Life Sciences, Vol. 56, Núm. 23-24, pp. 2177-2184

1994

  1. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin

    Journal of Neural Transmission, Vol. 96, Núm. 1, pp. 63-79

  2. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids

    Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 47-58

1993

  1. An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity

    Behavioural Brain Research, Vol. 57, Núm. 1, pp. 37-46

  2. Motor disturbances induced by an acute dose of Δ9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations

    Pharmacology, Biochemistry and Behavior, Vol. 45, Núm. 2, pp. 291-298